Dr. Farid Berenji is a hematologist / oncologist in Buffalo. He is a cancer specialist trained in blood disorders and the medical treatment of malignancies.
Yes, Dr. Farid Berenji is accepting new patients at this office.
45 Spindrift Drive, Suite 102, Buffalo, NY 14221
Open | Lunch | Close | |
---|---|---|---|
Mon | 12:00 - 1:00 pm | ||
Tue | 12:00 - 1:00 pm | ||
Wed | 12:00 - 1:00 pm | ||
Thu | 12:00 - 1:00 pm | ||
Fri | 12:00 - 1:00 pm |
Dr. Farid Berenji graduated from Shahid Beheshti University of Medical Sciences before completing a residency in Internal Medicine at Rochester General Hospital, University of Rochester. He then completed a fellowship in Hematology and Oncology at Wilmot Cancer Center, Strong Memorial Hospital and University of Rochester School of Medicine and De.
Dr. Berenji has one office in New York where he specializes in Hematology / Oncology and Internal Medicine.
Dr. Berenji works with eight doctors including Dr. Ronald Kossow and Dr. W. Sam Yi.
As a hematologist / oncologist in New York, Dr. Berenji is capable of diagnosing and treating patients with blood-related disorders, malignancies, or cancers. Dr. Berenji may treat a range of conditions ranging from the the common to the very rare and complex. As a result, Dr. Berenji may provide care as part of a multidisciplinary team, working in conjunction with other specialists to ensure the highest possible standard of care.
The specialty of internal medicine is an area of primary care for adults. Dr. Berenji specializes in diagnosing and treating cross-system illnesses that may affect multiple organ systems. When necessary, Dr. Berenji also can refer patients to specialists. For example, patients with serious gastrointestinal issues may be referred to a gastroenterologist for additional diagnostic tests or treatment options.
Rochester General Hospital, University of Rochester
Residency in Internal Medicine
Beheshti University of Medical Sciences in Tehran, Iran
Residency in Pathology
Wilmot Cancer Center, Strong Memorial Hospital and University of Rochester School of Medicine and De
Fellowship in Hematology and Oncology